Osteonecrosis of the jaw under palbociclib: A case series description.
Chabnam YosofiSophie Cairon-LejeuneClaudia Lefeuvre-PlesseElisabeth PolardMarie BrietSolène-Florence Kammerer-JacquetLouise TriquetLucie-Marie ScailteuxPublished in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2023)
We did not identify a specific pattern that could suggest a triggering role of palbociclib in the development of ONJ.
Keyphrases